Synakis Engages Community at Ophthalmic Drug Delivery Summit, Glaucoma 360, and OBIO Investment Summit

February 3, 2026

Synakis CEO Thierry Nivaggioli presented at the 4th Annual Ophthalmic Drug Delivery Summit (ODDS), January 27-29, 2026, in San Francisco, CA. The summit brought together experts in the field to discuss the future of ophthalmic therapies.

Learn more about ODDS

Synakis CEO Thierry Nivaggioli also showcased our novel long-acting intraocular pressure (IOP)-lowering technology for glaucoma at the Glaucoma 360 New Horizons Forum, January 30-31, 2026, in San Francisco, and joined the expert panel for “The Perfect Dose: Innovating Drugs and Drug Delivery.”

Learn more about Glaucoma 360

Synakis Director of R&D Adam Forman presented at the Ontario Bioscience Innovation Organization (OBIO) Investment Summit, February 3-5, 2026, in Toronto, ON. At the summit, Adam was interviewed by Next Great Big Ideas (NGBi) podcast host Jim Wilson.

Watch the interview here

Synakis CEO Thierry Nivaggioli (left) at the Ophthalmic Drug Delivery Summit.

Synakis’ CEO Thierry Nivaggioli presenting at the Glaucoma 360 New Horizons Forum.

Synakis Director of R&D Adam Forman presenting at the OBIO Investment Summit.